BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7861968)

  • 1. Immunochemical quantitation of bromodeoxyuridine: application to cell-cycle kinetics.
    Dolbeare F; Selden JR
    Methods Cell Biol; 1994; 41():297-316. PubMed ID: 7861968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
    Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
    BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
    Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
    Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From flow cytometric BrdUrd data to cell population growth and doubling time.
    Torricelli A; Bisiach M; Spinelli L; Ubezio P
    Cytometry; 1997 Nov; 29(3):222-32. PubMed ID: 9389439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of flow cytometry in the measurement of cell mitotic cycle.
    Keng PC
    Int J Cell Cloning; 1986 Sep; 4(5):295-311. PubMed ID: 2430028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle analysis using numerical simulation of bivariate DNA/bromodeoxyuridine distributions.
    Yanagisawa M; Dolbeare F; Todoroki T; Gray JW
    Cytometry; 1985 Nov; 6(6):550-62. PubMed ID: 4064838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific staining of iododeoxyuridine and bromodeoxyuridine in tumors double labelled in vivo: a cell kinetic analysis.
    Pollack A; Terry NH; Wu CS; Wise BM; White RA; Meistrich ML
    Cytometry; 1995 May; 20(1):53-61. PubMed ID: 7541331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric BrdUrd-pulse-chase study of X-ray-induced alterations in cell cycle progression.
    Higashikubo R; Ragouzis M; Roti Roti JL
    Cell Prolif; 1996 Jan; 29(1):43-57. PubMed ID: 8603109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part I: Historical perspectives, histochemical methods and cell kinetics.
    Dolbeare F
    Histochem J; 1995 May; 27(5):339-69. PubMed ID: 7657555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
    Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
    Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Flow cytometric analysis of cell proliferation kinetics using the anti-BrdUrd antibody].
    Sasaki K; Murakami T; Takahashi M
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2338-44. PubMed ID: 2751315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method for kinetic analysis of drug-induced cell cycle perturbations.
    Ubezio P; Filippeschi S; Spinelli L
    Cytometry; 1991; 12(2):119-26. PubMed ID: 1710959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous flow cytometric detection of cellular c-myc protein, incorporated bromodeoxyuridine, and DNA.
    Rosette CD; DeTeresa PS; Pallavicini MG
    Cytometry; 1990; 11(4):547-51. PubMed ID: 2111761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of denaturation with HCl on the immunological staining of bromodeoxyuridine incorporated into DNA.
    Sasaki K; Adachi S; Yamamoto T; Murakami T; Tanaka K; Takahashi M
    Cytometry; 1988 Jan; 9(1):93-6. PubMed ID: 2457476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
    Bertuzzi A; Faretta M; Gandolfi A; Sinisgalli C; Starace G; Valoti G; Ubezio P
    Bull Math Biol; 2002 Mar; 64(2):355-84. PubMed ID: 11926121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid and simple estimation of cell cycle parameters by continuous labeling with bromodeoxyuridine.
    Sasaki K; Murakami T; Takahashi M
    Cytometry; 1987 Sep; 8(5):526-8. PubMed ID: 3311660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous cell kinetics in tumors analyzed with a simulation model for bromodeoxyuridine single and multiple labeling.
    Baisch H; Otto U; Hatje U; Fack H
    Cytometry; 1995 Sep; 21(1):52-61. PubMed ID: 8529471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoblasts already in the DNA synthesis phase of the cell cycle can be reversibly arrested at the R/G transition.
    Lavoie J; Drouin R
    Chromosoma; 2001 Dec; 110(7):501-10. PubMed ID: 11862457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry after bromodeoxyuridine labeling to measure S and G2+M phase durations plus doubling times in vitro and in vivo.
    Terry NH; White RA
    Nat Protoc; 2006; 1(2):859-69. PubMed ID: 17406318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.